Literature DB >> 10782497

The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening?

J K Preiksaitis1.   

Abstract

Mesh:

Year:  2000        PMID: 10782497     DOI: 10.1016/s0887-7963(00)80003-6

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


× No keyword cloud information.
  5 in total

1.  Seroprevalence of cytomegalovirus among some voluntary blood donors at the 37 military hospital, accra, ghana.

Authors:  Aa Adjei; Hb Armah; Eg Narter-Olaga
Journal:  Ghana Med J       Date:  2006-09

Review 2.  Risk of cytomegalovirus transmission by blood products after solid organ transplantation.

Authors:  Deborah Jebakumar; Patti Bryant; Walter Linz
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-04-23

3.  Utilization management in the blood transfusion service.

Authors:  Jeremy Ryan Andrew Peña; Walter Sunny Dzik
Journal:  Clin Chim Acta       Date:  2013-09-29       Impact factor: 3.786

4.  High incidence of Epstein-Barr virus, cytomegalovirus and human herpesvirus 6 infections in children with cancer.

Authors:  Jaroslav Michálek; Radek Horvath
Journal:  BMC Pediatr       Date:  2002-01-10       Impact factor: 2.125

5.  Pathogen inactivation/reduction of platelet concentrates: turning theory into practice.

Authors:  B S Gathof; M E Tauszig; S M Picker
Journal:  ISBT Sci Ser       Date:  2010-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.